AI Summary

Researchers at Bar‑Ilan University’s Azrieli Faculty of Medicine identified blood‑based biomarkers that reliably predict which mice will respond to an experimental combination therapy for latent autoimmune diabetes in adults (LADA). In the study, the therapy restored normal blood‑sugar levels in roughly one‑third of the treated mice and promoted regeneration of insulin‑producing pancreatic cells. The work highlights how early‑stage LADA patients, who often receive type‑2 diabetes treatments due to ongoing insulin production, could be better matched to appropriate therapies.

AI summaries can be wrong sometimes—always verify important details using the source article.